Magrolimab
Showing 26 - 30 of 30
MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)
Active, not recruiting
- Myelodysplastic Syndromes
- Magrolimab
- +2 more
-
Birmingham, Alabama
- +168 more
Dec 7, 2022
Acute Myeloid Leukemia Trial in United States (Atezolizumab, Hu5F9-G4)
Terminated
- Acute Myeloid Leukemia
-
Sacramento, California
- +3 more
Dec 3, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in United Kingdom (Hu5F9-G4)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
-
Cardiff, United Kingdom
- +4 more
Feb 19, 2019